4: LABORATORY FINDINGS

PART 4
LABORATORY FINDINGS


In order to avoid repetition, ‘laboratory error’ has been omitted from the differential diagnoses in this chapter. However, it should always be borne in mind that factors such as mislabelling or misidentification of samples, errors introduced by the laboratory machinery (especially certain in-house laboratories where quality control is inadequate) and errors due to ageing samples or incorrect collection techniques can all cause apparent abnormalities. Where a test result is unexpectedly abnormal, it should be repeated, preferably by a different method. It is also important to remember that reference intervals are usually based on the values into which 95% of the healthy population would fall, so small changes outside these values may not be significant. Finally, each laboratory establishes its own reference intervals, due to differences in testing methodology and local factors, and thus when comparing results over a course of time, it is best to use the same laboratory.


4.1 Biochemical findings


4.1.1 Albumin


Decreased


  • Relative (dilutional)

Decreased production


  • Chronic inflammatory disease*
  • Hepatic failure* q.v.

Decreased protein intake


  • Malabsorption*
  • Maldigestion
  • Malnutrition

Increased loss


  • Cutaneous lesions, e.g.

    • Burns

  • External haemorrhage*, e.g.

    • Coagulopathy q.v.
    • Gastrointestinal neoplasia
    • Gastrointestinal ulceration
    • External parasites
    • Trauma

  • Protein-losing enteropathy*

    • Acute gastrointestinal infection, e.g. viral
    • Cardiac disease
    • Inflammatory bowel disease
    • Gastrointestinal neoplasia
    • Gastrointestinal parasitism
    • Gastrointestinal ulceration
    • Lymphangiectasia

      • Intestinal inflammation
      • Intestinal neoplasia
      • Lymphangitis
      • Primary/congenital
      • Venous hypertension
      • Protein-losing nephropathy q.v.

Sequestration


  • Body cavity effusion* q.v.

Increased


  • Artefact

    • Lipaemia

  • Haemoconcentration*

    • Dehydration

4.1.2 Alanine transferase


Decreased (minimal clinical significance)


  • Chronic liver disease
  • Normal variation*
  • Nutritional deficiency

    • Vitamin B6
    • Zinc

Increased

Artefact


  • Haemolysis
  • Lipaemia

Drugs/toxins


  • Barbiturates
  • Cimetidine
  • Colchicine
  • Cyclophosphamide
  • Danazol
  • Diazepam (C)
  • Glucocorticoids
  • Griseofulvin
  • Itraconazole
  • Ketoconazole
  • Methimazole
  • Methotrexate
  • Metronidazole
  • Mexiletine
  • Nandrolone
  • NSAIDs, e.g.

    • Ibuprofen
    • Paracetamol
    • Phenylbutazone

  • Oxytetracycline
  • Phenobarbitone
  • Phenylbutazone
  • Phenytoin
  • Primidone
  • Procainamide
  • Salicylates
  • Tetracycline
  • Trimethoprim/sulphonamide

Extrahepatic disease


  • Anoxia
  • Endocrine disease, e.g.

    • Hyperadrenocorticism
    • Hyperthyroidism (C)
    • Diabetes mellitus

  • Inflammatory disease, e.g.

    • Pancreatitis
    • Muscle disease, e.g. muscular dystrophy (D), trauma

Hepatic disease


  • Cholangiohepatitis* q.v.
  • Cholangitis* q.v.
  • Chronic hepatitis* q.v.
  • Cirrhosis*
  • Copper storage disease (D)
  • Feline infectious peritonitis* (C)
  • Hepatotoxin
  • Lipidosis
  • Neoplasia, e.g.

    • Hepatocellular adenocarcinoma*
    • Lymphoma*

  • Trauma*

4.1.3 Alkaline phosphatase


Increased


  • Normal in young growing animals*

Artefact


  • Haemolysis
  • Hyperbilirubinaemia
  • Lipaemia

Drugs/toxins


  • Aflatoxin
  • Barbiturates
  • Cimetidine
  • Colchicine
  • Cyclophosphamide
  • Danazol
  • Diazepam (C)
  • Glucocorticoids
  • Griseofulvin
  • Itraconazole
  • Ketoconazole
  • Methimazole
  • Methotrexate
  • Metronidazole
  • Mexiletine
  • Nandrolone
  • NSAIDs, e.g.

    • Ibuprofen
    • Paracetamol
    • Phenylbutazone

  • Oxytetracycline
  • Phenobarbitone
  • Phenoxy acid herbicides
  • Phenylbutazone
  • Phenytoin
  • Primidone
  • Procainamide
  • Salicylates
  • Trimethoprim/sulphonamide

Extrahepatic disease


  • Bile duct neoplasia
  • Bone disease, e.g.

    • Fracture
    • Osteomyelitis

  • Cholecystitis*
  • Cholelithiasis
  • Diabetes mellitus*
  • Diaphragmatic hernia*
  • Ehrlichiosis
  • Gall bladder mucocoele
  • Hyperadrenocorticism
  • Hyperthyroidism (C)*
  • Pancreatic neoplasia
  • Pancreatitis*
  • Right-sided congestive heart failure*
  • Septicaemia*

Hepatic disease


  • Cholangiohepatitis* q.v.
  • Chronic hepatitis* q.v.
  • Cirrhosis* q.v.
  • Copper storage disease (D)
  • Feline infectious peritonitis* (C)
  • Hepatic lipidosis (C)
  • Hepatic neoplasia*, e.g.

    • Haemangiosarcoma
    • Hepatocellular carcinoma
    • Lymphoma
    • Metastatic carcinoma

4.1.4 Ammonia


Decreased (minimal clinical significance)

Drugs


  • Diphenhydramine
  • Enemas
  • Lactulose
  • Oral antibiotics, e.g.

    • Aminoglycosides
    • Probiotics

Increased

Artefact


  • Delay in sample analysis
  • Fluoride/oxalate anticoagulants
  • Strenuous exercise

Drugs


  • Ammonium salts
  • Asparaginase
  • Diuretics

Hepatic insufficiency


  • Decreased functional hepatic mass, e.g.

    • Diffuse chronic hepatic disease

  • Decreased portal blood flow to the liver, e.g.

    • Acquired portosystemic shunt
    • Congenital portosystemic shunt

Miscellaneous


  • High-protein diet*
  • Intestinal haemorrhage
  • Urea cycle disorders
  • Selective cobalamin deficiency, e.g. border collie

4.1.5 Amylase


Increased

Drugs/toxins


  • Azathioprine
  • Carbamate
  • Diazoxide
  • Frusemide
  • Glucocorticoids
  • l-Asparaginase
  • Metronidazole
  • Oestrogens
  • Potassium bromide
  • Sulphonamides
  • Tetracyclines
  • Thiazide diuretics

Intestinal disease*

Pancreatic disease*


  • Necrosis
  • Neoplasia
  • Pancreatic duct obstruction
  • Pancreatitis*

Reduced glomerular filtration q.v.


  • Pre-renal disease*
  • Renal disease*
  • Post-renal disease*

4.1.6 Aspartate aminotransferase


Increased

Artefact


  • Haemolysis
  • Lipaemia

Drugs/toxins


  • Barbiturates
  • Carbamate
  • Glucocorticoids
  • Griseofulvin
  • Ketoconazole
  • NSAIDs, e.g.

    • Ibuprofen
    • Paracetamol
    • Phenobarbitone
    • Phenylbutazone
    • Primidone
    • Salicylates

Haemolysis*


  • Hepatic disease* q.v.
  • Muscle damage*

    • Exercise
    • Inflammation
    • Intramuscular injection
    • Ischaemia
    • Necrosis
    • Neoplasia
    • Trauma

4.1.7 Bilirubin


Decreased (minimal clinical significance)

Artefact


  • Prolonged exposure to sunlight or fluorescent light

Increased (see also Jaundice)

Artefact


  • Haemolysis
  • Lipaemia

Drugs/toxins


  • Barbiturates
  • Blue-green algae
  • Glucocorticoids
  • Glyphosphate
  • Griseofulvin
  • Ketoconazole
  • Metronidazole
  • Phenobarbitone
  • Plastic explosives
  • Primidone
  • NSAIDs, e.g.

    • Ibuprofen
    • Paracetamol
    • Phenylbutazone

  • Salicylates

Pre-hepatic


  • Haemolysis*

Hepatic, e.g.


  • Diffuse hepatocellular disease
  • Cholestatic liver disease* q.v.

Post-hepatic, e.g.


  • Biliary obstruction* q.v.

Miscellaneous


  • Bile sludging with dehydration and anorexia (C)
  • Decreased rate of excretion (functional cholestasis) in sepsis

4.1.8 Bile acids/dynamic bile acid test


Failure to stimulate


  • Cholestyramine
  • Delayed gastric emptying
  • Failure to feed a sufficiently high-fat meal for bile acid stimulation test
  • Malabsorption
  • Rapid intestinal transit time
  • Normal

Increased


  • Artefact

    • Haemolysis
    • Lipaemia

  • Decreased bile acid removal from portal blood

    • Portosystemic shunt

      • Acquired
      • Congenital

  • Decreased excretion bile acids

    • Hepatic disease
    • Cholestatic disease* q.v.
    • Hepatic parenchymal disease* q.v.
    • Secondary hepatic disease*

  • Drugs

    • Ursodeoxycholic acid

4.1.9 C-reactive protein (D)


Decreased


  • Severe obesity

Increased


  • Extreme exercise
  • Inflammation*, e.g.

    • Arthritis (including IMPA)
    • Haemolytic anaemia, pancreatitis, SRMA

  • Infection, e.g.

    • Bordetella
    • E. coli
    • Ehrlichia
    • Leishmania
    • Parvovirus
    • Pyometra

  • Neoplasia*, e.g.
  • Haemangiosarcoma
  • Leukaemia
  • Lymphoma
  • Parturition*
  • Pregnancy (period of time)
  • Tissue trauma*

4.1.10 Cholesterol


Decreased

Artefact


  • Intravenous dipyrone

Drugs


  • Azathioprine
  • Oral aminoglycosides

Gastrointestinal


  • Hepatic insufficiency* q.v.
  • Maldigestion/malabsorption* q.v.
  • Protein-losing enteropathy* q.v.

Increased


  • Idiopathic hyperlipidaemia
  • Postprandial hyperlipidaemia

Artefact


  • Hyperbilirubinaemia
  • Lipaemia

Drugs


  • Corticosteroids
  • Phenytoin
  • Thiazide diuretics

Breed related


  • Hypercholesterolaemia of the briard, rough collie and Shetland sheepdog (D)

Secondary hyperlipidaemia


  • Cholestatic disease* q.v.
  • Diabetes mellitus*
  • Hyperadrenocorticism
  • Hypothyroidism* (D)
  • Nephrotic syndrome
  • Pancreatic disease
  • Protein-losing nephropathy

4.1.11 Creatinine


Decreased


  • Poor body condition

Increased


  • Increased protein catabolism, e.g. heavily muscled dogs
  • Pre-renal azotaemia*
  • Renal azotaemia*

    • Acute kidney injury
    • Chronic kidney disease

  • Post-renal azotaemia*

    • (See Urea q.v.)

4.1.12 Creatine kinase


Mild increase (e.g. 2–3x upper reference interval)


  • Intramuscular injections*
  • Muscle biopsy
  • Muscle damage
  • Physical activity*
  • Prolonged recumbency*
  • Restraint*

Moderate to marked increase


  • Anorexia
  • Convulsions*
  • Endocrine, e.g.

    • Hyperadrenocorticism
    • Hypothyroidism (D)
    • Hyperthyroidism (C)

  • Feline lower urinary tract disease
  • Masticatory myopathy
  • Muscle damage
  • Myopathies

    • Inherited, e.g.

      • Hereditary Labrador retriever myopathy
      • Muscular dystrophy
      • Myotonia

    • Inflammatory/infectious, e.g.

      • Immune-mediated polymyositis
      • Neosporosis
      • Toxoplasmosis

    • Nutritional, e.g.

      • Selenium deficiency
      • Vitamin E deficiency

  • Neuropathies
  • Toxins, e.g.

    • Carbamate
    • Lily poisoning
    • Monensin
    • Phenoxy acid herbicides

  • Thromboembolic disease
  • Trauma*
  • Tremors/shivering q.v.

4.1.13 Ferritin


Decreased


  • Iron deficiency disorders q.v.
  • Acute/chronic inflammation
  • Portosystemic shunts
  • Young animals

Increased


  • Cortisol excess (D)
  • Haemolysis*
  • Iatrogenic, e.g.

    • Injections, diet

  • Inflammation*
  • Liver disease*
  • Neoplasia*

    • Lymphoma

  • Repeated blood transfusions

4.1.14 Fibrinogen


Decreased


  • Artefact

    • Clot
    • Incorrect anticoagulant

  • Disseminated intravascular coagulation*
  • Excessive blood loss*
  • Hereditary fibrinogen deficiency/abnormality
  • Severe hepatic insufficiency

Increased


  • Breed related

    • Cavalier King Charles spaniels

  • Haemoconcentration
  • Inflammation*
  • Parturition*
  • Pregnancy*
  • Renal disease*

4.1.15 Folate


Decreased


  • Dietary deficiency
  • Proximal small intestinal disease*

Increased


  • Dietary/parenteral supplementation
  • Exocrine pancreatic insufficiency
  • Small intestinal bacterial overgrowth*

4.1.16 Fructosamine


Decreased


  • Hyperthyroidism (C)
  • Insulin overdosage
  • Persistent hypoglycaemia q.v., e.g.

    • Insulinoma

Increased


  • Hypothyroidism (D)*
  • Persistent hyperglycaemia, e.g.

    • Diabetes mellitus*

4.1.17 Gamma-glutamyl transferase


Increased

Artefact


  • Lipaemia

Drugs


  • Barbiturates
  • Glucocorticoids
  • Griseofulvin
  • Ketoconazole
  • NSAIDs, e.g.

    • Ibuprofen
    • Paracetamol
    • Phenylbutazone

  • Phenobarbitone
  • Primidone
  • Salicylates

Extrahepatic disease


  • Bile duct neoplasia
  • Cholecystitis*
  • Cholelithiasis
  • Diabetes mellitus*
  • Diaphragmatic hernia*
  • Gall bladder mucocoele
  • Hyperadrenocorticism
  • Hyperthyroidism (C)*
  • Pancreatic neoplasia
  • Pancreatitis*
  • Right-sided congestive heart failure*
  • Septicaemia*

Hepatic disease


  • Cholangiohepatitis* q.v.
  • Chronic hepatitis* q.v.
  • Cirrhosis* q.v.
  • Copper storage disease (D)
  • Feline infectious peritonitis* (C)
  • Hepatic lipidosis (C)
  • Hepatic neoplasia*, e.g.

    • Haemangiosarcoma
    • Hepatocellular carcinoma
    • Lymphoma
    • Metastatic carcinoma

4.1.18 Gastrin


Increased


  • Antral G-cell hyperplasia
  • Atrophic gastritis
  • Chronic omeprazole administration
  • Gastric outlet obstruction
  • Gastrinoma
  • Hyperparathyroidism
  • Renal disease* q.v.
  • Short bowel syndrome

4.1.19 Globulins


Decreased


  • Normal in greyhounds
  • External haemorrhage, e.g.

    • Coagulopathy q.v.
    • Gastrointestinal neoplasia
    • Gastrointestinal ulceration
    • Trauma*

  • Hepatic insufficiency* q.v.
  • Neonate*
  • Protein-losing enteropathies* q.v.

Increased

Polyclonal


  • Dehydration
  • Infectious disease

    • Bacterial disease*, e.g.

      • Bacterial endocarditis

        • Brucellosis
        • Pyoderma*

    • Fungal disease, e.g.

      • Blastomycosis

        • Coccidioidomycosis
        • Histoplasmosis

    • Parasitic disease*, e.g.

      • Demodicosis*

        • Dirofilariasis
        • Scabies*

    • Protozoal disease
    • Rickettsial disease, e.g.

      • Ehrlichiosis

        • Viral disease*, e.g.
        • Feline immunodeficiency virus* (C)
        • Feline infectious peritonitis* (C)
        • Feline leukaemia virus* (C)

    • Immune mediated/inflammatory

      • Acute inflammatory response, e.g.

        • Hepatitis*
        • Nephritis*
        • Suppurative diseases*

      • Allergies*
      • Autoimmune polyarthritis
      • Bullous pemphigoid
      • Immune-mediated haemolytic anaemia
      • Immune-mediated thrombocytopenia
      • Pemphigus complex
      • Systemic lupus erythematosus

    • Neoplasia

      • Lymphoma

Monoclonal/oligoclonal


  • Cutaneous amyloidosis
  • Idiopathic
  • Macroglobulinaemia
  • Plasmacytic gastroenterocolitis
  • Infectious

    • Ehrlichiosis
    • Leishmaniasis

  • Neoplastic

    • Extramedullary plasmacytoma
    • Lymphoma*
    • Multiple myeloma

4.1.20 Glucose


Decreased


  • Polycythaemia q.v.
  • Renal disease* q.v.
  • Sepsis*

Artefact


  • Prolonged contact of serum/plasma with erythrocytes

Drugs/toxins


  • Anabolic steroids
  • Beta blockers, e.g.

    • Propranolol

  • Ethanol
  • Ethylene glycol
  • Insulin
  • Salicylates
  • Sulphonylurea
  • Xylitol

Endocrine


  • Growth hormone deficiency
  • Hypoadrenocorticism (D)
  • Hypopituitarism
  • Insulinoma

Hepatic


  • Hepatic failure

    • Cirrhosis*
    • Hepatic necrosis, e.g.

      • Infection
      • Toxin
      • Trauma

    • Portosystemic shunts (acquired or congenital)

Idiopathic


  • Juvenile
  • Neonatal

Neoplastic*


  • Hepatic leiomyoma/leiomyosarcoma
  • Hepatic/splenic haemangiosarcoma
  • Hepatocellular carcinoma
  • Pancreatic

Substrate deficiency


  • Glycogen storage disease
  • Hunting dog hypoglycaemia
  • Juvenile hypoglycaemia
  • Neonatal hypoglycaemia
  • Pregnancy hypoglycaemia
  • Reduced dietary intake of glucose or its precursors, e.g.

    • Severe malnutrition

  • Sepsis

Increased


  • Excitement
  • Pancreatitis* (and other pancreatic diseases)
  • Parenteral nutrition
  • Postprandial
  • Renal insufficiency* q.v.
  • Stress hyperglycaemia*
  • Supplementation, e.g. IV fluids

Artefact


  • Azotaemia

Drugs/toxins


  • Daffodil
  • Ethylene glycol
  • Glucagon
  • Glucocorticoids
  • Hydrochlorothiazide
  • Ketamine
  • Megestrol acetate
  • Oestrogens
  • Phenytoin
  • Progestagens
  • Snake venom
  • Thiazide diuretics
  • Xylazine (and other alpha-2 agents)

Endocrine


  • Acromegaly
  • Diabetes mellitus*
  • Hyperadrenocorticism
  • Hyperpituitarism
  • Hyperthyroidism
  • Pheochromocytoma

Progesterone induced*, e.g.


  • Dioestrus
  • Lactation
  • Pregnancy

4.1.21 Iron


Decreased


  • Acute phase inflammatory reactions*
  • Chronic inflammatory disease*
  • Hypothyroidism (D)
  • Portosystemic shunt
  • Renal disease* q.v.

Chronic external blood loss*, e.g.


  • Chronically bleeding external masses*
  • External parasites, e.g.

    • Heavy flea burden*

  • Gastrointestinal*, e.g.

    • Clotting disorder q.v.
    • Neoplasia
    • Parasitism
    • Ulceration

Decreased intake


  • Milk-only diet in immature animals

Neoplasia


  • Lymphoma
  • Osteosarcoma

Increased


  • Haemolysis* q.v.
  • Ingestion of iron supplements/parenteral overdose
  • Liver disease* q.v.
  • Refractory anaemia

4.1.22 Lactate dehydrogenase


Increased

Artefact


  • Haemolysis
  • Sample ageing

Cardiac muscle disorders


  • Degeneration
  • Ischaemia

    • Aortic thromboembolism*
    • Bacterial endocarditis
    • Dirofilariasis
    • Myocardial infarction

  • Neoplasia
  • Trauma

Miscellaneous


  • Hepatocellular damage* q.v.
  • Hyperthyroidism* (C)

Respiratory disease*


  • Necrosis
  • Pulmonary thromboembolism

Skeletal muscle disorders


  • Exertional rhabdomyolysis
  • Neoplasia*
  • Seizures*
  • Trauma*

Endocrine


  • Hyperadrenocorticism*
  • Hypothyroidism* (D)

Inflammatory/infectious


  • Bacterial*
  • Protozoal*

Idiopathic


  • Idiopathic polymyositis
  • Masticatory myopathy

Inherited myopathies


  • Hereditary Labrador retriever myopathy
  • Muscular dystrophy
  • Myotonia

Metabolic


  • Glycogen storage diseases
  • Mitochondrial myopathy

Nutritional


  • Vitamin E deficiency

Vascular


  • Aortic thromboembolism* (C)

4.1.23 Lipase


Decreased

Artefact


  • Haemolysis
  • Hyperbilirubinaemia
  • Lipaemia

Increased

Drugs


  • Azathioprine
  • Diazoxide
  • Frusemide
  • Glucocorticoids
  • l-Asparaginase
  • Metronidazole
  • Oestrogens
  • Potassium bromide
  • Sulphonamides
  • Tetracyclines
  • Thiazide diuretics

Pancreatic disease


  • Necrosis
  • Neoplasia
  • Pancreatic duct obstruction
  • Pancreatitis*

Reduced glomerular filtration


  • Pre-renal disease* q.v.
  • Renal disease* q.v.
  • Post-renal disease* q.v.

4.1.24 Triglycerides


Decreased


  • Artefact

    • Intravenous dipyrone

  • Hyperthyroidism* (C)
  • Protein-losing enteropathy*
  • Drugs

    • Ascorbic acid therapy

Increased


  • Artefact

    • Hyperbilirubinaemia

  • Postprandial*

Drugs


  • Glucocorticoids
  • Megestrol acetate

Primary/idiopathic hyperlipidaemia


  • Familial hyperchylomicronaemia in the cat
  • Idiopathic hypertriglyceridaemia of the miniature schnauzer
  • Idiopathic hypertriglyceridaemia
  • Lipoprotein lipase deficiency (C)
  • Transient hyperlipidaemia and anaemia in kittens (C)

Secondary hyperlipidaemia


  • Acute pancreatitis*
  • Cholestasis*
  • Diabetes mellitus*
  • Hepatic insufficiency* q.v.
  • Hyperadrenocorticism
  • Hypothyroidism* (D)
  • Nephrotic syndrome

4.1.25 Troponin


Increased

Cardiac disease, e.g.


  • Aortic stenosis
  • Arrhythmogenic right ventricular cardiomyopathy
  • Bradyarrhythmias
  • Dilated cardiomyopathy
  • Mitral valve disease
  • Pericardial effusion
  • Pulmonary hypertension
  • Pulmonic stenosis

Drugs/toxins


  • Albuterol
  • Anaesthesia/sedation
  • Benfluorex
  • Doxorubicin
  • Oleander
  • Phenazopyridine
  • Phenylpropanolamine
  • Ractopamine
  • Viper envenomation

Infections


  • Babesiosis
  • Dirofilariasis
  • Ehrlichiosis
  • Leishmaniasis
  • Pyometra

Miscellaneous


  • Anaemia
  • Azotaemia/renal disease
  • Brachycephalic obstructive airway syndrome
  • Gastric dilatation and volvulus
  • Heat stroke
  • Hyperadrenocorticism
  • Hypoadrenocorticism
  • Neoplasia, e.g. lymphoma
  • Pancreatitis
  • Steroid-responsive meningitis–arteritis

Physiological


  • Breed variation (greyhounds)
  • High-intensity exercise
  • Old age

4.1.26 Trypsin-like immunoreactivity


Decreased


  • Exocrine pancreatic insufficiency
  • Very-low-protein diet

Increased


  • High-protein diet
  • Pancreatitis*
  • Post-pancreatic obstruction
  • Reduced glomerular filtration rate

4.1.27 Urea


Increased

Pre-renal


  • Dehydration*
  • Gastrointestinal bleeding
  • Heart failure*
  • High-protein diet*
  • Hypoadrenocorticism (D)
  • Increased catabolic state, e.g.

    • Fever*

  • Shock* q.v.
  • Tetracyclines

Renal

Acute kidney injury


  • Diabetes mellitus*
  • Drugs/toxins

    • ACE inhibitors
    • Anaesthetics
    • Antibiotics, e.g.

      • Aminoglycosides
      • Amphotericin B
      • Cephalosporins
      • Tetracyclines

    • Borax
    • Calcium edetate
    • Chemotherapeutics, e.g.

      • Cisplatin

    • Cimetidine
    • Corticosteroids
    • Dipyrone (metamizole)
    • Heavy metals, e.g.

      • Arsenic
      • Lead
      • Mercury

    • Hymenoptera stings
    • Intravenous radiographic contrast agents
    • Iron/iron salts

  • Lily ingestion (C)
  • Melamine toxicity
  • Methylene blue

    • NSAIDs
    • Organic compounds, e.g.

      • Ethylene glycol
      • Herbicides
      • Pesticides

    • Pigments, e.g.

      • Myoglobin/haemoglobin
      • Paraquat
      • Plastic explosives
      • Salt
      • Snake venom

  • Hypercalcaemia
  • Immune-mediated diseases, e.g.

    • Glomerulonephritis
    • Systemic lupus erythematosus

  • Infection e.g.

    • Leptospirosis
    • Pyelonephritis

  • Ischaemia

    • Decreased cardiac output*
    • Extensive burns
    • Hyper-/hypothermia* q.v.
    • Prolonged anaesthesia*
    • Renal vessel thrombosis
    • Shock, e.g.

      • Hypovolaemia
      • Sepsis*

    • Transfusion reactions
    • Trauma*

  • Urinary tract obstruction*

Chronic kidney disease, e.g.


  • Subsequent to acute kidney injury
  • Glomerulonephritis*
  • Interstitial nephritis*
  • Nephrotoxins

Post-renal


  • Bladder obstruction*, e.g.

    • Blood clot
    • Neoplasia
    • Polyp*
    • Urolith*

  • Bladder trauma
  • Ureteral obstruction (may need to be bilateral to cause azotaemia)
  • Urethral obstruction, e.g.

    • Neoplasia
    • Urolith

  • Urethral trauma
  • Uroabdomen

Decreased


  • Normal in neonates*
  • Dialysis/over-hydration
  • Diuresis, e.g.

    • Fluid and drug therapy*

  • Liver insufficiency, e.g.

    • Cirrhosis
    • Portosystemic shunt*

  • Low-protein diet/malnutrition*
  • Polyuria q.v., e.g.

    • Diabetes insipidus
    • Hyperadrenocorticism

  • Pregnancy*
  • Urea cycle enzyme deficiency

4.1.28 Vitamin B12 (cobalamin)


Decreased


  • Exocrine pancreatic insufficiency
  • Hepatic lipidosis (C)
  • Inflammatory biliary tract disorders
  • Inherited defect of absorption, e.g. border collie
  • Intestinal mucosal disease*
  • Pancreatitis

Increased


  • Vitamin B12 supplementation

4.1.29 Zinc


Decreased


  • Decreased dietary intake
  • Zinc-responsive dermatosis

Increased


  • Ingestion of zinc-containing objects, e.g.

    • Coins

4.2 Haematological findings


4.2.1 Regenerative anaemia


HAEMORRHAGE


Internal


  • Bleeding tumour*
  • Coagulopathy q.v.
  • Traumatic injury*

External


  • Bleeding tumour*
  • Coagulopathy q.v.
  • Epistaxis q.v.
  • Haematemesis q.v.
  • Haematuria q.v.
  • Intestinal blood loss q.v.
  • Traumatic injury*

Parasitism*


  • Ancylostoma spp.
  • Fleas
  • Lice
  • Ticks
  • Uncinaria spp.

HAEMOLYSIS


Acquired defects of red cells


  • Hypophosphataemia

Chemical damage


  • Copper
  • Cyclic hydrocarbons
  • Heavy metals
  • Propylene glycol

Oxidative damage (Heinz body anaemia)


  • Benzocaine toxicity
  • DL-methionine toxicity
  • Garlic toxicity
  • Glycol toxicity
  • High doses of vitamin K
  • Lymphoma
  • Metabolic disease

    • Diabetes mellitus*
    • Hyperthyroidism* (C)
    • Renal disease*

  • Methylene blue
  • Onion toxicity
  • Paracetamol toxicity
  • Phenazopyridine (C)
  • Phenolic compound toxicity, e.g.

    • Mothballs

  • Propylene toxicity
  • Vitamin K3 toxicity
  • Zinc toxicity

Genetic defects of red cells


  • Feline porphyria
  • Hereditary elliptocytosis
  • Hereditary haemolysis in Abyssinian and Somali cats (C)
  • Hereditary stomatocytosis
  • Methaemoglobin reductase deficiency
  • Non-spherocytic haemolytic anaemia of beagles (D)
  • Phosphofructokinase deficiency (D)
  • Pyruvate kinase deficiency

Immune mediated


  • Primary (autoimmune haemolytic anaemia)*

Drugs/toxins


  • Anti-arrhythmics
  • Anticonvulsants
  • Bee envenomation
  • Cephalosporins
  • Chlorpromazine
  • Copper
  • Dipyrone
  • Levamisole
  • Methimazole
  • Methylene blue
  • NSAIDs, e.g.

    • Paracetamol

  • Penicillins
  • Propylthiouracil
  • Quinidine
  • Trimethoprim/sulphonamide

Immunological


  • Anti-lymphocyte globulin therapy
  • Neonatal isoerythrolysis
  • Systemic lupus erythematosus
  • Transfusion reactions

Infectious


  • Ancylostoma spp.
  • Babesiosis
  • Cytauxzoonosis
  • Dirofilariasis
  • Ehrlichiosis
  • Feline leukaemia virus* (C)
  • Haemobartonellosis
  • Leishmaniasis
  • Leptospirosis*
  • Trypanosomiasis (D)
  • Uncinaria spp.

Neoplastic


  • Haemangiosarcoma
  • Lymphoproliferative disease, e.g.

    • Leukaemia
    • Lymphoma*

Mechanical injury of red cells


  • Dirofilariasis
  • Disseminated intravascular coagulation*
  • Enlarged spleen
  • Glomerulonephritis
  • Haemolytic–uraemic syndrome
  • Neoplasia causing microangiopathic haemolytic anaemia, e.g.

    • Splenic haemangiosarcoma*

  • Patent ductus arteriosus
  • Vasculitis

4.2.2 Poorly/non-regenerative anaemia


Normal


  • Young animals

Acute, pre-regenerative anaemia

Anaemia of chronic disease/associated with systemic disease


  • Chronic inflammatory disease*
  • Chronic kidney disease* q.v.
  • Cytauxzoonosis
  • Feline immunodeficiency virus* (C)
  • Feline infectious peritonitis* (C)
  • Feline leukaemia virus* (C)
  • Hepatic disease* q.v.
  • Histoplasmosis
  • Hypoadrenocorticism (D)
  • Hypothyroidism* (D)
  • Leishmaniasis
  • Malignant neoplasia
  • Trypanosomiasis (D)

Bone marrow disorders – reduced red cell production

Aplastic anaemia


  • Drugs/toxins

    • Albendazole
    • Anti-cancer chemotherapeutics
    • Chloramphenicol
    • Cyclic hydrocarbons
    • DDT
    • Diazoxide
    • Oestrogens
    • Phenylbutazone
    • Sulpha drugs
    • Trichloroethylene
    • Trimethoprim/sulphadiazine

  • Hyperoestrogenism, e.g.

    • Iatrogenic
    • Sertoli cell tumour

  • Infection

    • Ehrlichiosis
    • Viruses, e.g.

      • Feline leukaemia virus* (C)
      • Parvovirus*

  • Irradiation

Haematopoietic neoplasia


  • Lymphoproliferative

    • Lymphoid leukaemia

      • Acute lymphoblastic leukaemia
      • Chronic lymphocytic leukaemia

    • Granular lymphocytic leukaemia
    • Lymphoma
    • Multiple myeloma

  • Myeloproliferative

    • Acute monocytic leukaemia
    • Acute myeloid leukaemia
    • Acute myelomonocytic leukaemia
    • Chronic myeloid/granulocytic leukaemia

Myelodysplasia


  • Primary
  • Secondary

    • Cobalamin or folate deficiencies
    • Drug-induced toxicosis
    • Immune-mediated diseases
    • Neoplastic diseases

Myelophthisis


  • Granulomatous inflammation

    • Fungi
    • Histoplasmosis
    • Tuberculosis

  • Myelofibrosis

    • Idiopathic
    • Lymphoproliferative
    • Myeloproliferative
    • Other types of neoplasia
    • Prolonged marrow stimulation, e.g.

      • Chronic haemolytic anaemia

    • Radiation

  • Neoplasia

    • Leukaemia
    • Metastatic neoplasia, e.g.

      • Carcinoma
      • Melanoma

Pure red cell aplasia


  • Feline leukaemia virus* (C)
  • Immune mediated

Defects in haemoglobin synthesis


  • Copper deficiency
  • Erythropoietic porphyria
  • Hereditary porphyria
  • Iron deficiency anaemia q.v.
  • Lead poisoning
  • Vitamin B6 deficiency

Defects in nucleotide synthesis

Nutrient deficiencies


  • Cobalt
  • Folic acid
  • Vitamin B12

Erythropoietin deficiency


  • Chronic kidney disease* q.v.

Iron deficiency

Inadequate intake


  • Dietary deficiency, e.g.

    • Milk diet

Inadequate stores


  • Neonates*

Chronic external haemorrhage


  • Bleeding tumour*
  • Coagulopathy q.v.
  • Epistaxis q.v.
  • Haematemesis q.v.
  • Haematuria q.v.
  • Intestinal blood loss q.v.
  • Parasitism*

    • Ancylostoma spp.
    • Fleas
    • Lice
    • Ticks
    • Uncinaria spp.

Rapid erythropoiesis


  • Erythropoietin therapy of anaemia
  • Neonates

Repeat phlebotomy


  • Blood donors*
  • Frequent blood sampling of small patients*
  • Therapeutic phlebotomy, e.g.

    • Polycythaemia

Traumatic injury


  • Sideroblastic anaemia

4.2.3 Polycythaemia


Relative polycythaemia

Dehydration*


  • Burns
  • Diarrhoea
  • Heat stroke
  • Polyuria without matching polydipsia
  • Vomiting
  • Water deprivation

Splenic contraction*


  • Excitement
  • Exercise
  • Stress

Primary polycythaemia


  • Myeloproliferative disease (polycythaemia vera/primary erythrocytosis)

Secondary polycythaemia

Physiologically appropriate


  • Altitude
  • Chronic respiratory disease, e.g.

    • Feline asthma*
    • Interstitial fibrosis
    • Neoplasia*

  • Haemoglobinopathies
  • Right-to-left congenital cardiac shunt, e.g.

    • Atrial septal defect with pulmonic stenosis
    • Pulmonary arteriovenous fistula
    • Reverse-shunting patent ductus arteriosus
    • Reverse-shunting ventricular septal defect
    • Tetralogy of Fallot

Physiologically inappropriate


  • Extra-renal neoplasia

    • Caecal leiomyosarcoma
    • Hepatic carcinoma
    • Hepatoblastoma
    • Nasal fibrosarcoma

  • Hyperadrenocorticism
  • Hyperthyroidism* (C)
  • Non-neoplastic renal diseases

    • Fatty infiltration of the kidney
    • Hydronephrosis
    • Renal capsular effusion
    • Renal cysts

  • Renal neoplasia

    • Adenocarcinoma
    • Fibrosarcoma
    • Lymphoma
    • Nephroblastoma

  • Toxins, e.g.

    • Carbamate

4.2.4 Thrombocytopenia


Decreased production

Bone marrow neoplasia, e.g.


  • Lymphoproliferative disease
  • Metastatic disease
  • Myeloproliferative disease

Drugs


  • Albendazole
  • Antibiotics, e.g.

    • Chloramphenicol
    • Trimethoprim/sulphonamide

  • Chemotherapeutic/cytotoxic drugs
  • Chloramphenicol
  • Diazoxide
  • Griseofulvin
  • Methimazole
  • Oestrogens
  • Phenylbutazone
  • Phenytoin
  • Propylthiouracil
  • Ribavirin
  • Thiazide diuretics

Infection


  • Bacterial

    • Endotoxaemia*

  • Fungal

    • Blastomycosis
    • Coccidioidomycosis
    • Cryptococcosis
    • Histoplasmosis

  • Parasitic

    • Cytauxzoonosis
    • Hepatozoonosis

  • Rickettsial

    • Ehrlichiosis
    • Rocky Mountain spotted fever

  • Viral

    • Canine distemper virus* (D)
    • Canine parvovirus* (D)
    • Feline immunodeficiency virus* (C)
    • Feline infectious enteritis* (C)
    • Feline leukaemia virus* (C)

Miscellaneous


  • Haemophagocytic syndrome
  • Myelofibrosis

    • Idiopathic
    • Neoplasia, e.g.

      • Myeloproliferative disease

    • Prolonged marrow stimulation
    • Secondary to sepsis

Immune-mediated destruction


  • Primary immune-mediated thrombocytopenia
  • Concurrent immune-mediated thrombocytopenia and immune-mediated haemolytic anaemia (Evans syndrome)

Drugs/toxins


  • Cephalosporins
  • Chlorpromazine
  • Colchicine
  • Cytotoxic drugs
  • Dipyrone
  • Heparin
  • Levamisole
  • Methimazole
  • Modified live vaccines
  • NSAIDs
  • Oestrogens
  • Penicillins
  • Propylthiouracil
  • Quinidine
  • Trimethoprim/sulphonamide

Secondary immune-mediated thrombocytopenia


  • Infections

    • Babesiosis
    • Dirofilariasis
    • Ehrlichiosis
    • Feline immunodeficiency virus* (C)
    • Feline leukaemia virus* (C)
    • Leptospirosis

  • Neonatal alloimmune thrombocytopenia
  • Neoplasia, e.g.

    • Lymphoma*
    • Solid tumours

  • Systemic lupus erythematosus
  • Transfusion reactions

Increased utilisation/non-immune destruction


  • Disseminated intravascular coagulation
  • Haemolytic–uraemic syndrome
  • Microangiopathic destruction
  • Septicaemia
  • Snake venom

Chronic/severe haemorrhage


  • Coagulopathy
  • Neoplasia

Vasculitis


  • Canine adenovirus-1
  • Canine herpesvirus
  • Dirofilariasis
  • Ehrlichiosis
  • Feline infectious peritonitis* (C)
  • Neoplasia
  • Polyarteritis nodosa
  • Rocky Mountain spotted fever
  • Septicaemia
  • Systemic lupus erythematosus

Sequestration


  • Hepatomegaly* q.v.
  • Sepsis*
  • Splenomegaly* q.v.

    • Chronic infection*
    • Haematoma*
    • Immune-mediated haemolytic anaemia*
    • Neoplasia

      • Haemangioma
      • Haemangiosarcoma
      • Mast cell
      • Metastatic

    • Portal hypertension
    • Splenic torsion
    • Splenitis
    • Systemic lupus erythematosus

4.2.5 Thrombocytosis


Normal


  • May be normal in older animals

Splenic contraction


  • Excitement*
  • Exercise*
  • Stress*

Post splenectomy

Primary


  • Essential thrombocytosis

Reactive


  • Bradycardia q.v.
  • Chronic haemorrhage* q.v.
  • Fractures*
  • Gastrointestinal disease* q.v.
  • Hyperadrenocorticism
  • Hypercoagulability/disseminated intravascular coagulation
  • Hyperviscosity syndromes
  • Hypotension*
  • Infection
  • Inflammation/immune-mediated disease*
  • Metastatic carcinoma
  • Non-specific bone marrow stimulation
  • Paraneoplastic

    • Bronchoalveolar carcinoma
    • Chronic myeloid leukaemia
    • Gingival carcinoma
    • Metastatic squamous cell carcinoma
    • Osteosarcoma

  • Polycythaemia q.v.
  • Shock* q.v.

Rebound


  • Secondary to resolution of previous thrombocytopenia

4.2.6 Neutrophilia


Immunodeficiency syndromes, e.g.


  • Canine leukocyte adhesion deficiency (D)
  • Weimaraner immunodeficiency (D)

Inflammatory conditions – acute or chronic*, e.g.


  • Chemical exposure

Immune-mediated disease*, e.g.


  • Haemolytic anaemia*
  • Polyarthritis
  • Systemic lupus erythematosus

Infections


  • Bacterial*
  • Fungal
  • Protozoal
  • Viral*

Neoplasia


  • Necrosis*
  • Secondary bacterial infection*
  • Ulceration*

Tissue necrosis, e.g.


  • Large tumours*
  • Pancreatitis*
  • Pansteatitis

Toxins


  • Endotoxin*
  • Snakebite

Physiological


  • Stress

    • Adrenaline release
    • Corticosteroid (endogenous or exogenous)

Primary


  • Myeloproliferative disease

    • Acute myeloid leukaemia
    • Chronic myeloid leukaemia

Reactive


  • Haemolysis* q.v.
  • Haemorrhage*
  • Neoplasia*
  • Oestrogen toxicity
  • Recent surgery*
  • Trauma*

4.2.7 Neutropenia


Decreased neutrophil survival


  • Haemophagocytic syndromes
  • Immune-mediated neutropenia (D)
  • Parvovirus enteritis*

Sepsis/endotoxaemia*, e.g.


  • Acute salmonellosis*
  • Aspiration pneumonia*
  • Peritonitis*
  • Pyometra*
  • Pyothorax*

Reduced neutrophil release

Trapped neutrophil syndrome in border collie (D)


Reduced neutrophil production


  • Canine cyclic haematopoiesis

Acute viral infections*


  • Canine parvovirus* (D)
  • Feline immunodeficiency virus* (C)
  • Feline leukaemia virus* (C)
  • Feline panleukopenia virus* (C)
  • Infectious canine hepatitis* (D)

Bone marrow disease


  • Aplastic anaemia

    • Ehrlichiosis
    • Idiopathic
    • Toxicity

      • Oestrogen
      • Phenylbutazone

  • Bone marrow neoplasia, e.g.

    • Lymphoproliferative disease
    • Metastatic neoplasia
    • Myeloproliferative disease

  • Disseminated granulomatous disease
  • Immune-mediated destruction of neutrophil precursors
  • Myelodysplasia
  • Myelophthisis

Bone marrow suppression


  • Drugs

    • Albendazole
    • Azathioprine
    • Busulphan
    • Carbimazole
    • Carboplatin
    • Chlorambucil
    • Chloramphenicol
    • Cyclophosphamide
    • Cytarabine
    • Diazoxide
    • Doxorubicin
    • Frusemide
    • Griseofulvin
    • Hydroxyurea
    • Lomustine
    • Melphalan
    • Methimazole
    • Oestrogen
    • Phenobarbitone
    • Phenylbutazone
    • Trimethoprim/sulphonamide (C)
    • Vinblastine

  • Oestrogen toxicity, e.g.

    • Iatrogenic
    • Sertoli cell tumour

  • Radiation therapy

4.2.8 Lymphocytosis


Miscellaneous


  • Chronic infection*
  • Hypoadrenocorticism (D)
  • Recent vaccination*

Neoplasia


  • Leukaemia

    • Acute lymphoblastic leukaemia
    • Chronic lymphocytic leukaemia

  • Stage V lymphoma

Physiological*


  • Excitement*
  • Exercise*
  • Immature animal*
  • Post vaccination*
  • Stress (adrenaline response)*

4.2.9 Lymphopenia


Drugs


  • Albendazole
  • Azathioprine
  • Busulphan
  • Carbimazole
  • Carboplatin
  • Chlorambucil
  • Chloramphenicol
  • Corticosteroids
  • Cyclophosphamide
  • Cyclosporin
  • Cytarabine
  • Diazoxide
  • Doxorubicin
  • Frusemide
  • Griseofulvin
  • Hydroxyurea
  • Lomustine
  • Melphalan
  • Phenylbutazone
  • Trimethoprim/sulphonamide (C)
  • Vinblastine

Endocrine


  • Hyperadrenocorticism

Immunodeficiency syndromes, e.g.


  • Basset hound
  • Cardigan Welsh corgi
  • Jack Russell terrier

Infectious/inflammatory


  • Septicaemia*

Viral infections, e.g.


  • Canine distemper virus* (D)
  • Coronavirus*
  • Feline immunodeficiency virus* (C)
  • Feline leukaemia virus* (C)
  • Infectious canine hepatitis* (D)
  • Parvovirus

Loss of lymph


  • Chylothorax
  • Lymphangiectasia
  • Protein-losing enteropathy* q.v.

Physiological


  • Stress (corticosteroid response)*

4.2.10 Monocytosis


Chronic inflammation


  • Granulomatous inflammation
  • Pyogranulomatous inflammation
  • Suppuration*
  • Tissue necrosis*

Corticosteroids


  • Hyperadrenocorticism
  • Iatrogenic
  • Stress

Infections

Fungal, e.g.


  • Coccidioidomycosis

Parasitic, e.g.


  • Leishmaniasis

Viral, e.g.


  • Feline immunodeficiency virus* (C)

Bacterial e.g.


  • Rickettsial

Haemolytic/haemorrhagic diseases* q.v.

Immune-mediated disease, e.g.


  • Immune-mediated haemolytic anaemia*
  • Immune-mediated polyarthritis

Neoplasia


  • Monocytic leukaemia
  • Myelomonocytic leukaemia
  • Tumours with necrotic centres*

4.2.11 Eosinophilia


Hormonal


  • Hypoadrenocorticism
  • Oestrus in some bitches

Immune mediated


  • Allergies *

    • Atopy*
    • Feline asthma* (C)
    • Flea allergy*
    • Food allergies*

  • Canine panosteitis (D)
  • Eosinophilic bronchopneumopathy (D)
  • Eosinophilic gastroenteritis*
  • Eosinophilic granuloma complex*
  • Eosinophilic myositis
  • Feline hypereosinophilic syndrome (C)
  • Pemphigus foliaceus

Infection

Bacterial*

Fungal, e.g.


  • Aspergillosis
  • Cryptococcosis

Parasites*, e.g.


  • Aelurostrongylus abstrusus
  • Ancylostoma spp.
  • Angiostrongylus vasorum
  • Capillaria aerophila
  • Dirofilaria immitis
  • Oslerus osleri
  • Pneumonyssoides caninum
  • Trichuris vulpis

Neoplastic


  • Eosinophilic leukaemia

Tumour-associated eosinophilia


  • Fibrosarcoma
  • Myeloproliferative disease
  • Lymphoma
  • Mast cell tumour
  • Mucinous carcinomas
  • Transitional cell carcinoma

4.2.12 Eosinopenia



  • Acute infection*
  • Acute inflammation*
  • Bone marrow aplasia/hypoplasia
  • Glucocorticoid therapy*
  • Hyperadrenocorticism
  • Stress*

4.2.13 Mastocytemia



  • Disseminated mast cell neoplasia
  • Mast cell leukaemia
  • Mast cell tumour*, e.g.

    • Intestinal tract
    • Spleen

  • Severe inflammation

4.2.14 Basophilia



  • Chronic granulocytic leukaemia
  • Hyperlipoproteinaemia
  • Hypersensitivity reactions
  • Lymphoma
  • Lymphomatoid granulomatosis
  • Lymphoplasmacytic gastroenteritis
  • Mast cell tumours*
  • Parasitism, especially dirofilariasis

4.2.15 Increased buccal mucosal bleeding time (disorders of primary haemostasis)


Thrombocytopenia q.v.

Thrombocytopathia

Acquired


  • Chronic anaemia
  • Disseminated intravascular coagulation
  • Drugs/toxins

    • Antibiotics
    • Barbiturates
    • Calcium channel blockers
    • Colloids
    • Heparin
    • Hetastarch
    • NSAIDs, especially aspirin
    • Propranolol
    • Theophylline
    • Snake venom

  • Hepatic disease*
  • Infection

    • Ehrlichiosis
    • Feline leukaemia virus* (C)

  • Neoplasia*, e.g.

    • Lymphocytic leukaemia
    • Multiple myeloma

  • Paraproteinaemias

    • Benign macroglobulinaemia
    • Polyclonal gammopathies

  • Uraemia* q.v.

Inherited


  • Basset hound thrombopathia (D)
  • Canine thrombasthenic thrombopathia of otter hounds and great pyrenees (D)
  • Chédiak–Higashi syndrome (C)
  • Cocker spaniel bleeding disorders (D)
  • Cyclic haematopoiesis (grey collie)
  • Glanzmann’s thrombasthenia (D)
  • von Willebrand’s disease* (D)

4.2.16 Increased prothrombin time (disorders of extrinsic and common pathways)



  • Artefact
  • Deficiency of factor II, V, VII or X
  • Disseminated intravascular coagulation
  • Hypo- or dysfibrinogenaemia
  • Liver disease*, e.g.

    • Portosystemic shunt
    • Vitamin K antagonism*

4.2.17 Increased partial thromboplastin time or activated clotting time (disorders of intrinsic and common pathways)



  • Colloid administration
  • Disseminated intravascular coagulation
  • Factor II, V, X, XI or XII deficiency
  • Haemophilia A (factor VIII deficiency)
  • Haemophilia B (factor IX deficiency)
  • Haemorrhage
  • Hypo- or dysfibrinogenaemia
  • Liver disease* q.v.
  • Vitamin K antagonism*
  • Vitamin K-dependent coagulopathy

4.2.18 Increased fibrin degradation products



  • Disseminated intravascular coagulation
  • Hepatic disease* q.v.
  • Hyperfibrinogenolysis
  • Internal haemorrhage
  • Thrombosis*
  • Vitamin K antagonism*

4.2.19 Decreased fibrinogen levels



  • Artefact

    • Clot
    • Incorrect anticoagulant

  • Disseminated intravascular coagulation*
  • Excessive blood loss*
  • Hereditary fibrinogen deficiency
  • Immune-mediated haemolytic anaemia
  • Severe hepatic deficiency

4.2.20 Decreased antithrombin III levels



  • Heparin therapy
  • Hepatic disease* q.v.
  • Hypercoagulability, e.g.

    • Disseminated intravascular coagulation

  • Protein-losing enteropathy* q.v., e.g.

    • Parvovirus enteritis

  • Protein-losing nephropathy* q.v.

4.3 Electrolyte and blood gas findings


4.3.1 Total calcium


Decreased


  • Acute pancreatitis*
  • Acute kidney injury q.v.
  • Canine distemper virus* (D)
  • Chronic kidney disease* q.v.
  • Exocrine pancreatic insufficiency (D)
  • Hypoalbuminaemia* q.v.
  • Hypomagnesaemia q.v.
  • Hypoproteinaemia
  • Hypovitaminosis D
  • Iatrogenic (post thyroidectomy)*
  • Idiopathic
  • Infarction of parathyroid gland adenomas
  • Intestinal malabsorption*
  • Lactational hypocalcaemia
  • Medullary carcinoma of the thyroid (C-cell tumour)
  • Nutritional secondary hyperparathyroidism
  • Primary hypoparathyroidism
  • Puerperal tetany (eclampsia)*
  • Rhabdomyolysis
  • Tumour lysis syndrome

Artefact


  • Haemolysis
  • Incorrect anticoagulant

Drugs/toxins


  • Anticonvulsants
  • Calcitonin therapy
  • EDTA
  • Ethylene glycol
  • Frusemide
  • Glucagon
  • Intravenous phosphate administration
  • Mithramycin
  • Oxalate toxicity
  • Pamidronate
  • Phosphate-containing enemas
  • Sodium bicarbonate
  • Transfusion using citrated blood

Increased


  • Acute kidney injury q.v.
  • Artefact

    • Lipaemia

  • Chronic kidney disease* q.v.
  • Dehydration/hyperalbuminaemia* q.v.
  • Granulomatous disease
  • Hypervitaminosis A
  • Hypervitaminosis D
  • Hypoadrenocorticism (D)
  • Idiopathic hypercalcaemia of cats (C)
  • Physiological

    • Postprandial
    • Young dog*

  • Tertiary hyperparathyroidism

Drugs/toxins


  • Anabolic steroids
  • Calcipotriol
  • Cholecalciferol rodenticides
  • Hydralazine
  • Jasmine
  • Oestrogen
  • Oral or intravenous calcium
  • Oral phosphate binders
  • Paracetamol
  • Parenteral calcium administration
  • Progesterone
  • Testosterone
  • Trilostane
  • Vitamin D analogues

Hypercalcaemia of malignancy


  • Carcinoma

    • Bronchogenic
    • Mammary
    • Nasal cavity
    • Prostatic
    • Squamous cell
    • Thyroid

  • Haematological malignancies

    • Lymphoma*
    • Multiple myeloma
    • Myeloproliferative disease

  • Metastatic or primary bone neoplasia q.v.
  • Pseudohyperparathyroidism

    • Apocrine gland adenocarcinoma*
    • Lymphoma*

Primary hyperparathyroidism


  • Hereditary neonatal hyperparathyroidism
  • Multiple endocrine neoplasia
  • Parathyroid gland adenoma
  • Parathyroid gland carcinoma
  • Primary hyperplasia of the parathyroid glands

Skeletal lesions


  • Bone metastases
  • Hypertrophic osteodystrophy
  • Osteomyelitis
  • Systemic mycoses

4.3.2 Chloride


Note: Most causes of hyperchloraemia also cause concurrent hypernatraemia, and if changes are proportionate, it is usually easier to look for causes of hypernatraemia. Formulae to correct chloride to account for sodium changes have been suggested as follows:


images

Stay updated, free articles. Join our Telegram channel

Sep 3, 2017 | Posted by in SMALL ANIMAL | Comments Off on 4: LABORATORY FINDINGS

Full access? Get Clinical Tree

Get Clinical Tree app for offline access